SORRENTO THERAPEUTICS INC (SRNE) Institutional Shareholders
SORRENTO THERAPEUTICS INC (SRNE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $70 in SRNE holdings during the latest filing period.
Vsm Wealth Advisory, Llc is currently the largest disclosed institutional shareholder of SRNE tracked by InsiderSet, reporting ownership valued at approximately $66 in its June 30, 2026 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed SRNE value among the investors covered in this analysis. Major shareholders include Vsm Wealth Advisory, Llc, Huntington National Bank, and several other long-term asset managers with concentrated positions in SORRENTO THERAPEUTICS INC (SRNE).
This page ranks the largest institutional SRNE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
2
Total Reported Value
$70
Largest Holder
Vsm Wealth Advisory, Llc
Largest Position
$66
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
12
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Vsm Wealth Advisory, Llc | 0.00% | 110,100 | $66 | — | — | — | |
| Huntington National Bank | 0.00% | 5,001 | $4 | — | — | — |
Frequently asked questions about SRNE
Who are the largest institutional holders of SRNE?
The largest institutional holders of SRNE reported in the latest SEC Form 13F filings include Vsm Wealth Advisory, Llc and Huntington National Bank. InsiderSet ranks institutional holders by their latest reported SRNE position.
What is SRNE institutional ownership?
This page tracks SRNE positions reported by institutional investment managers through SEC Form 13F. SORRENTO THERAPEUTICS INC (SRNE) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own SRNE?
InsiderSet currently tracks 2 institutional managers reporting SRNE holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of SRNE shareholders.
How much SRNE stock do institutions own?
Institutional investment managers disclosed approximately $70 in SRNE holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was SRNE institutional ownership last updated?
The latest SRNE institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional SRNE holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its SRNE position after the reporting date.
Are institutions buying or selling SRNE?
Institutional buying and selling can be analyzed by comparing SRNE positions across consecutive 13F reporting periods. InsiderSet's SRNE Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View SRNE ownership changes.
How has SRNE institutional ownership changed over time?
InsiderSet tracks SRNE institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.